Ryufin

1. Accounting information General Corbion is the global market leader in lactic acid and lactic acid derivatives and a leading supplier of food preservation solutions, functional blends, and algae ingredients. Leveraging our advanced capabilities in fermentation and preservation technology, we help customers differentiate their products in diverse markets ranging from food and animal nutrition to home & personal care, pharmaceuticals, electronics, medical devices, and bioplastics.Corbion is based in Amsterdam, the Netherlands and listed on Euronext Amsterdam.These consolidated financial statements cover the year 2024, which ended at the balance sheet date of 31 December 2024. The consolidated financial statements drawn up by the Board of Management have been approved by the Supervisory Board on 26 February 2025. They will be presented to the annual General Meeting of Shareholders for ado

Netherlands · NL0010583399 · reports in EUR · Europe

The answers

From the annual report for the year to Dec 31, 2024. Each line says what it is based on.

Is it growing?Fair
Revenue +1.9% in the year to Dec 31, 2024, on the year before.
Is it a good business?Good
It earned 25% on its shareholders' equity in the year to Dec 31, 2024.
Is it safe?Fair
Equity is 50% of its assets, and operations brought in cash in the year.
Is the price fair?n/a
Not answered: no exchange publishes this company's price for free reuse, so there is no P/E here.

The year

Year to Dec 31, 2024, consolidated, in EUR.

€1.3B

revenue

6.0%

operating margin

€192M

net profit

Year by year

As filed; an earlier year can differ from its own report when the company restated it.

Dec 2021Dec 2022Dec 2023Dec 2024
Revenue€1.1B€1.5B€1.3B€1.3B
Operating profit€82M€111M€77M€77M
Net profit to shareholders€78M€90M€73M€192M
Earnings per share€1.33€1.53€1.23€3.29
Cash from operations€22M€39M€165M€184M
Cash€42M€58M€70M€49M
Total assets€1.3B€1.7B€1.7B€1.5B
Equity€554M€626M€636M€773M

What they do

In the company's own words, from the annual report.

Corbion is the global market leader in lactic acid and lactic acid derivatives and a leading supplier of food preservation solutions, functional blends, and algae ingredients. Leveraging our advanced capabilities in fermentation and preservation technology, we help customers differentiate their products in diverse markets ranging from food and animal nutrition to home & personal care, pharmaceuticals, electronics, medical devices, and bioplastics.

Source: the company’s annual financial report in ESEF, via filings.xbrl.org (XBRL International). Listed shares from ESMA’s FIRDS register; ESMA does not endorse this site. Ryufin computed the answers and ratios from the filed figures.